[Effect of long-term high-dose progesterone (Depo-Provera) therapy on endometrial carcinoma].
Szarvas
Z
Z
Zsolnai
B
B
Gimes
G
G
Hidvégi
J
J
D000368:Aged; D002277:Carcinoma / Q000188:drug therapy* / Q000648:ultrastructure; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004714:Endometrial Hyperplasia / Q000139:chemically induced / Q000473:pathology; D004717:Endometrium / Q000187:drug effects / Q000648:ultrastructure; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008855:Microscopy, Electron, Scanning; D011300:Preoperative Care; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000648:ultrastructure
D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
Tartós, nagy dózisú progesztogén (Depo-Provera) kezelés hatása az endometrium carcinomára.